Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 468,256 | 1,324,192 | 968,279 | 524,068 | 434,433 |
| Depreciation Amortization | 8,841 | 32,489 | 23,751 | 14,630 | 5,281 |
| Accounts receivable | 1,805 | -2,360 | -1,945 | -787 | 3,171 |
| Other Working Capital | 240,187 | 1,076,447 | 704,241 | 451,571 | 225,771 |
| Other Operating Activity | -856 | 59,055 | -31,651 | -29,422 | -72,580 |
| Operating Cash Flow | $718,233 | $2,489,823 | $1,662,675 | $960,060 | $596,076 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,697,729 | N/A | N/A | N/A |
| PPE Investments | -452,366 | N/A | -964,044 | -2,171 | -1,057 |
| Net Acquisitions | N/A | -74,416 | -74,416 | -74,190 | N/A |
| Purchase Of Investment | -72,500 | -504,740 | -348,027 | -348,027 | -54,427 |
| Sale Of Investment | 47,001 | 671,651 | 629,054 | 625,269 | 559,401 |
| Other Investing Activity | 0 | -8,946 | -8,946 | -8,946 | 0 |
| Investing Cash Flow | $-477,865 | $-1,614,180 | $-766,379 | $191,935 | $503,917 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,275,000 | 1,275,000 | N/A | N/A |
| Debt Issued | N/A | 1,954,475 | 1,954,475 | N/A | N/A |
| Debt Repayment | N/A | -1,000,000 | -1,000,000 | N/A | N/A |
| Common Stock Issued | N/A | 5,917 | 5,917 | 6,121 | 1,297 |
| Common Stock Repurchased | -50,100 | -1,227,383 | -1,146,846 | -1,000,353 | -708,781 |
| Dividend Paid | -222,343 | -900,629 | -686,381 | -454,881 | -233,815 |
| Other Financing Activity | -226 | -1,293,353 | -1,288,543 | 0 | 0 |
| Financing Cash Flow | $-272,669 | $-1,185,973 | $-886,378 | $-1,449,113 | $-941,299 |
| Beginning Cash Position | 618,696 | 929,026 | 929,026 | 929,026 | 929,026 |
| End Cash Position | 586,395 | 618,696 | 938,944 | 631,908 | 1,087,720 |
| Net Cash Flow | $-32,301 | $-310,330 | $9,918 | $-297,118 | $158,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | 718,233 | 2,489,823 | 1,662,675 | 960,060 | 596,076 |
| Capital Expenditure | -452,366 | N/A | -964,044 | -2,171 | -1,057 |
| Free Cash Flow | 265,867 | 2,489,823 | 698,631 | 957,889 | 595,019 |